Middleton & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,462
Closed -$366K 141
2019
Q2
$366K Hold
2,462
0.06% 121
2019
Q1
$324K Hold
2,462
0.05% 124
2018
Q4
$267K Sell
2,462
-1,397
-36% -$187K 0.05% 129
2018
Q3
$576K Hold
3,859
0.09% 116
2018
Q2
$595K Hold
3,859
0.1% 118
2018
Q1
$536K Sell
3,859
-331
-8% -$48.6K 0.1% 120
2017
Q4
$574K Hold
4,190
0.1% 123
2017
Q3
$543K Hold
4,190
0.1% 126
2017
Q2
$555K Hold
4,190
0.12% 107
2017
Q1
$516K Hold
4,190
0.11% 111
2016
Q4
$462K Hold
4,190
0.1% 121
2016
Q3
$495K Buy
4,190
+349
+9% +$41.1K 0.11% 123
2016
Q2
$430K Hold
3,841
0.1% 120
2016
Q1
$387K Hold
3,841
0.09% 122
2015
Q4
$408K Buy
+3,841
New +$396K 0.09% 121

Other funds holding LH

Middleton & Co's LH Position: Q3 2019 in Review

Middleton & Co sold out of Labcorp (LH) in Q3 2019, closing a stake of 2,462 shares — an estimated $366K sold.

Middleton & Co first reported a position in LH in Q4 2015 and held it in 15 quarters. The position peaked at $595K in Q2 2018. 739 funds tracked by Wall St. Rank hold LH as of Q3 2019.

  • Middleton & Co reported no remaining Labcorp position as of Q3 2019 after selling out during the quarter.
  • Middleton & Co sold 2,462 Labcorp shares in Q3 2019, an estimated $366K.
  • Middleton & Co first reported a position in Labcorp in Q4 2015 and held it in 15 quarters.
  • Middleton & Co's Labcorp position peaked at $595K in Q2 2018.
  • 739 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Middleton & Co's 13F filing for Q3 2019, filed 21 Oct 2019.